nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—SLC22A3—Adefovir Dipivoxil—hepatitis B	0.317	0.43	CbGbCtD
Imipramine—SLC22A3—Lamivudine—hepatitis B	0.186	0.252	CbGbCtD
Imipramine—SLC22A2—Lamivudine—hepatitis B	0.11	0.149	CbGbCtD
Imipramine—SLC22A1—Lamivudine—hepatitis B	0.0957	0.13	CbGbCtD
Imipramine—ABCB1—Lamivudine—hepatitis B	0.0293	0.0397	CbGbCtD
Imipramine—Hypertrophy of breast—Lamivudine—hepatitis B	0.00705	0.0453	CcSEcCtD
Imipramine—ORM1—saliva—hepatitis B	0.00498	0.141	CbGeAlD
Imipramine—Breast enlargement—Lamivudine—hepatitis B	0.00256	0.0164	CcSEcCtD
Imipramine—Abdominal cramps—Lamivudine—hepatitis B	0.00246	0.0158	CcSEcCtD
Imipramine—Bone marrow depression—Lamivudine—hepatitis B	0.00246	0.0158	CcSEcCtD
Imipramine—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00235	0.0151	CcSEcCtD
Imipramine—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00199	0.0128	CcSEcCtD
Imipramine—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00191	0.0123	CcSEcCtD
Imipramine—Hepatobiliary disease—Entecavir—hepatitis B	0.0019	0.0122	CcSEcCtD
Imipramine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00185	0.0119	CcSEcCtD
Imipramine—SLC6A4—blood plasma—hepatitis B	0.00185	0.0523	CbGeAlD
Imipramine—Hepatitis—Entecavir—hepatitis B	0.0018	0.0116	CcSEcCtD
Imipramine—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00176	0.0113	CcSEcCtD
Imipramine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00174	0.0111	CcSEcCtD
Imipramine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00172	0.0111	CcSEcCtD
Imipramine—HTR1A—blood plasma—hepatitis B	0.00164	0.0464	CbGeAlD
Imipramine—Immune system disorder—Entecavir—hepatitis B	0.00163	0.0104	CcSEcCtD
Imipramine—Neuropathy peripheral—Telbivudine—hepatitis B	0.00162	0.0104	CcSEcCtD
Imipramine—Alopecia—Entecavir—hepatitis B	0.00159	0.0102	CcSEcCtD
Imipramine—Mental disorder—Entecavir—hepatitis B	0.00158	0.0101	CcSEcCtD
Imipramine—Malnutrition—Entecavir—hepatitis B	0.00157	0.0101	CcSEcCtD
Imipramine—HTR7—blood plasma—hepatitis B	0.00157	0.0444	CbGeAlD
Imipramine—Hepatobiliary disease—Telbivudine—hepatitis B	0.00156	0.01	CcSEcCtD
Imipramine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00153	0.00983	CcSEcCtD
Imipramine—CYP2C19—blood plasma—hepatitis B	0.00153	0.0433	CbGeAlD
Imipramine—Gynaecomastia—Lamivudine—hepatitis B	0.00149	0.00954	CcSEcCtD
Imipramine—Hepatitis—Telbivudine—hepatitis B	0.00148	0.0095	CcSEcCtD
Imipramine—Hypoaesthesia—Telbivudine—hepatitis B	0.00147	0.00946	CcSEcCtD
Imipramine—Leukopenia—Entecavir—hepatitis B	0.0014	0.00901	CcSEcCtD
Imipramine—Sleep disorder—Lamivudine—hepatitis B	0.00139	0.00894	CcSEcCtD
Imipramine—Mediastinal disorder—Telbivudine—hepatitis B	0.00133	0.00856	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00133	0.00851	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00129	0.00831	CcSEcCtD
Imipramine—Malnutrition—Telbivudine—hepatitis B	0.00129	0.00827	CcSEcCtD
Imipramine—Anaphylactic shock—Entecavir—hepatitis B	0.00128	0.00822	CcSEcCtD
Imipramine—Infection—Entecavir—hepatitis B	0.00127	0.00817	CcSEcCtD
Imipramine—Dysgeusia—Telbivudine—hepatitis B	0.00126	0.0081	CcSEcCtD
Imipramine—Nervous system disorder—Entecavir—hepatitis B	0.00126	0.00806	CcSEcCtD
Imipramine—CYP1A2—blood plasma—hepatitis B	0.00125	0.0354	CbGeAlD
Imipramine—Skin disorder—Entecavir—hepatitis B	0.00124	0.00798	CcSEcCtD
Imipramine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00123	0.00786	CcSEcCtD
Imipramine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00122	0.00785	CcSEcCtD
Imipramine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00121	0.00779	CcSEcCtD
Imipramine—CYP2B6—blood plasma—hepatitis B	0.0012	0.0339	CbGeAlD
Imipramine—Ill-defined disorder—Telbivudine—hepatitis B	0.0012	0.00768	CcSEcCtD
Imipramine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00119	0.00764	CcSEcCtD
Imipramine—Affect lability—Lamivudine—hepatitis B	0.00119	0.00762	CcSEcCtD
Imipramine—Malaise—Telbivudine—hepatitis B	0.00116	0.00746	CcSEcCtD
Imipramine—Insomnia—Entecavir—hepatitis B	0.00116	0.00743	CcSEcCtD
Imipramine—Mood swings—Lamivudine—hepatitis B	0.00114	0.00733	CcSEcCtD
Imipramine—Somnolence—Entecavir—hepatitis B	0.00114	0.00731	CcSEcCtD
Imipramine—KCND3—liver—hepatitis B	0.00113	0.0321	CbGeAlD
Imipramine—Dyspepsia—Entecavir—hepatitis B	0.00113	0.00723	CcSEcCtD
Imipramine—CYP2E1—blood plasma—hepatitis B	0.00112	0.0318	CbGeAlD
Imipramine—Liver function test abnormal—Lamivudine—hepatitis B	0.00111	0.00715	CcSEcCtD
Imipramine—Gastrointestinal disorder—Entecavir—hepatitis B	0.00111	0.0071	CcSEcCtD
Imipramine—Fatigue—Entecavir—hepatitis B	0.0011	0.00709	CcSEcCtD
Imipramine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.0011	0.00706	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00109	0.00699	CcSEcCtD
Imipramine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00109	0.00697	CcSEcCtD
Imipramine—Discomfort—Telbivudine—hepatitis B	0.00108	0.00696	CcSEcCtD
Imipramine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00108	0.00692	CcSEcCtD
Imipramine—Gastrointestinal pain—Entecavir—hepatitis B	0.00105	0.00672	CcSEcCtD
Imipramine—CYP2C18—liver—hepatitis B	0.00103	0.0292	CbGeAlD
Imipramine—Nervous system disorder—Telbivudine—hepatitis B	0.00103	0.00662	CcSEcCtD
Imipramine—Thrombocytopenia—Telbivudine—hepatitis B	0.00103	0.00661	CcSEcCtD
Imipramine—Skin disorder—Telbivudine—hepatitis B	0.00102	0.00656	CcSEcCtD
Imipramine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00102	0.00656	CcSEcCtD
Imipramine—Abdominal pain—Entecavir—hepatitis B	0.00101	0.0065	CcSEcCtD
Imipramine—Body temperature increased—Entecavir—hepatitis B	0.00101	0.0065	CcSEcCtD
Imipramine—Pancytopenia—Lamivudine—hepatitis B	0.00099	0.00635	CcSEcCtD
Imipramine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000988	0.00634	CcSEcCtD
Imipramine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000988	0.00634	CcSEcCtD
Imipramine—CYP3A7—liver—hepatitis B	0.000982	0.0278	CbGeAlD
Imipramine—HTR2A—blood plasma—hepatitis B	0.000977	0.0277	CbGeAlD
Imipramine—Pollakiuria—Lamivudine—hepatitis B	0.000963	0.00618	CcSEcCtD
Imipramine—Insomnia—Telbivudine—hepatitis B	0.000951	0.00611	CcSEcCtD
Imipramine—Paraesthesia—Telbivudine—hepatitis B	0.000945	0.00606	CcSEcCtD
Imipramine—Dyspepsia—Telbivudine—hepatitis B	0.000926	0.00594	CcSEcCtD
Imipramine—Asthenia—Entecavir—hepatitis B	0.000919	0.0059	CcSEcCtD
Imipramine—Neuropathy peripheral—Lamivudine—hepatitis B	0.000911	0.00585	CcSEcCtD
Imipramine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000908	0.00583	CcSEcCtD
Imipramine—Fatigue—Telbivudine—hepatitis B	0.000907	0.00582	CcSEcCtD
Imipramine—Stomatitis—Lamivudine—hepatitis B	0.000906	0.00582	CcSEcCtD
Imipramine—Jaundice—Lamivudine—hepatitis B	0.000906	0.00582	CcSEcCtD
Imipramine—CYP3A4—blood plasma—hepatitis B	0.000905	0.0256	CbGeAlD
Imipramine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000896	0.00575	CcSEcCtD
Imipramine—CYP2D6—blood plasma—hepatitis B	0.00089	0.0252	CbGeAlD
Imipramine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000884	0.00567	CcSEcCtD
Imipramine—Hepatobiliary disease—Lamivudine—hepatitis B	0.000879	0.00564	CcSEcCtD
Imipramine—Diarrhoea—Entecavir—hepatitis B	0.000876	0.00562	CcSEcCtD
Imipramine—Agranulocytosis—Lamivudine—hepatitis B	0.000867	0.00557	CcSEcCtD
Imipramine—Feeling abnormal—Telbivudine—hepatitis B	0.000867	0.00556	CcSEcCtD
Imipramine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00086	0.00552	CcSEcCtD
Imipramine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000855	0.00549	CcSEcCtD
Imipramine—Dizziness—Entecavir—hepatitis B	0.000847	0.00543	CcSEcCtD
Imipramine—CYP3A7-CYP3A51P—liver—hepatitis B	0.000835	0.0236	CbGeAlD
Imipramine—Hepatitis—Lamivudine—hepatitis B	0.000834	0.00536	CcSEcCtD
Imipramine—Abdominal pain—Telbivudine—hepatitis B	0.000832	0.00534	CcSEcCtD
Imipramine—Body temperature increased—Telbivudine—hepatitis B	0.000832	0.00534	CcSEcCtD
Imipramine—Hypoaesthesia—Lamivudine—hepatitis B	0.00083	0.00533	CcSEcCtD
Imipramine—Vomiting—Entecavir—hepatitis B	0.000814	0.00523	CcSEcCtD
Imipramine—Rash—Entecavir—hepatitis B	0.000807	0.00518	CcSEcCtD
Imipramine—Dermatitis—Entecavir—hepatitis B	0.000807	0.00518	CcSEcCtD
Imipramine—Headache—Entecavir—hepatitis B	0.000802	0.00515	CcSEcCtD
Imipramine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000794	0.0051	CcSEcCtD
Imipramine—ORM1—blood—hepatitis B	0.000794	0.0225	CbGeAlD
Imipramine—Rash—Adefovir Dipivoxil—hepatitis B	0.000788	0.00506	CcSEcCtD
Imipramine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000787	0.00505	CcSEcCtD
Imipramine—Headache—Adefovir Dipivoxil—hepatitis B	0.000783	0.00502	CcSEcCtD
Imipramine—SLC22A4—blood—hepatitis B	0.000764	0.0216	CbGeAlD
Imipramine—Nausea—Entecavir—hepatitis B	0.000761	0.00488	CcSEcCtD
Imipramine—Asthenia—Telbivudine—hepatitis B	0.000755	0.00484	CcSEcCtD
Imipramine—Immune system disorder—Lamivudine—hepatitis B	0.000754	0.00484	CcSEcCtD
Imipramine—Mediastinal disorder—Lamivudine—hepatitis B	0.000752	0.00483	CcSEcCtD
Imipramine—Pruritus—Telbivudine—hepatitis B	0.000744	0.00478	CcSEcCtD
Imipramine—Nausea—Adefovir Dipivoxil—hepatitis B	0.000742	0.00476	CcSEcCtD
Imipramine—Alopecia—Lamivudine—hepatitis B	0.000737	0.00473	CcSEcCtD
Imipramine—SLC22A1—blood—hepatitis B	0.000727	0.0206	CbGeAlD
Imipramine—Malnutrition—Lamivudine—hepatitis B	0.000726	0.00466	CcSEcCtD
Imipramine—Diarrhoea—Telbivudine—hepatitis B	0.00072	0.00462	CcSEcCtD
Imipramine—Tension—Lamivudine—hepatitis B	0.000713	0.00457	CcSEcCtD
Imipramine—Dysgeusia—Lamivudine—hepatitis B	0.000711	0.00457	CcSEcCtD
Imipramine—Nervousness—Lamivudine—hepatitis B	0.000705	0.00453	CcSEcCtD
Imipramine—Dizziness—Telbivudine—hepatitis B	0.000696	0.00446	CcSEcCtD
Imipramine—Tremor—Lamivudine—hepatitis B	0.000681	0.00437	CcSEcCtD
Imipramine—SLC6A4—blood—hepatitis B	0.000677	0.0191	CbGeAlD
Imipramine—Ill-defined disorder—Lamivudine—hepatitis B	0.000674	0.00433	CcSEcCtD
Imipramine—Vomiting—Telbivudine—hepatitis B	0.000669	0.00429	CcSEcCtD
Imipramine—Rash—Telbivudine—hepatitis B	0.000663	0.00426	CcSEcCtD
Imipramine—Dermatitis—Telbivudine—hepatitis B	0.000663	0.00425	CcSEcCtD
Imipramine—Headache—Telbivudine—hepatitis B	0.000659	0.00423	CcSEcCtD
Imipramine—Malaise—Lamivudine—hepatitis B	0.000655	0.0042	CcSEcCtD
Imipramine—Syncope—Lamivudine—hepatitis B	0.000651	0.00418	CcSEcCtD
Imipramine—Leukopenia—Lamivudine—hepatitis B	0.00065	0.00417	CcSEcCtD
Imipramine—ABCB1—blood plasma—hepatitis B	0.000641	0.0181	CbGeAlD
Imipramine—Loss of consciousness—Lamivudine—hepatitis B	0.000638	0.0041	CcSEcCtD
Imipramine—Convulsion—Lamivudine—hepatitis B	0.000629	0.00404	CcSEcCtD
Imipramine—Nausea—Telbivudine—hepatitis B	0.000625	0.00401	CcSEcCtD
Imipramine—ORM1—liver—hepatitis B	0.000621	0.0176	CbGeAlD
Imipramine—Anxiety—Lamivudine—hepatitis B	0.000616	0.00396	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000614	0.00394	CcSEcCtD
Imipramine—Discomfort—Lamivudine—hepatitis B	0.000611	0.00392	CcSEcCtD
Imipramine—Dry mouth—Lamivudine—hepatitis B	0.000605	0.00388	CcSEcCtD
Imipramine—Confusional state—Lamivudine—hepatitis B	0.000598	0.00384	CcSEcCtD
Imipramine—Oedema—Lamivudine—hepatitis B	0.000593	0.0038	CcSEcCtD
Imipramine—Anaphylactic shock—Lamivudine—hepatitis B	0.000593	0.0038	CcSEcCtD
Imipramine—Infection—Lamivudine—hepatitis B	0.000589	0.00378	CcSEcCtD
Imipramine—Shock—Lamivudine—hepatitis B	0.000583	0.00374	CcSEcCtD
Imipramine—Nervous system disorder—Lamivudine—hepatitis B	0.000581	0.00373	CcSEcCtD
Imipramine—Thrombocytopenia—Lamivudine—hepatitis B	0.00058	0.00373	CcSEcCtD
Imipramine—Skin disorder—Lamivudine—hepatitis B	0.000576	0.0037	CcSEcCtD
Imipramine—HTR7—blood—hepatitis B	0.000574	0.0162	CbGeAlD
Imipramine—Hyperhidrosis—Lamivudine—hepatitis B	0.000573	0.00368	CcSEcCtD
Imipramine—SLC22A1—liver—hepatitis B	0.000569	0.0161	CbGeAlD
Imipramine—Anorexia—Lamivudine—hepatitis B	0.000565	0.00363	CcSEcCtD
Imipramine—CYP2C19—blood—hepatitis B	0.000561	0.0159	CbGeAlD
Imipramine—ADRA1A—blood—hepatitis B	0.000554	0.0157	CbGeAlD
Imipramine—SLC22A3—liver—hepatitis B	0.000544	0.0154	CbGeAlD
Imipramine—Insomnia—Lamivudine—hepatitis B	0.000536	0.00344	CcSEcCtD
Imipramine—KCNH2—blood—hepatitis B	0.000535	0.0151	CbGeAlD
Imipramine—Paraesthesia—Lamivudine—hepatitis B	0.000532	0.00342	CcSEcCtD
Imipramine—Somnolence—Lamivudine—hepatitis B	0.000527	0.00338	CcSEcCtD
Imipramine—Dyspepsia—Lamivudine—hepatitis B	0.000522	0.00335	CcSEcCtD
Imipramine—Decreased appetite—Lamivudine—hepatitis B	0.000515	0.00331	CcSEcCtD
Imipramine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000512	0.00328	CcSEcCtD
Imipramine—Fatigue—Lamivudine—hepatitis B	0.000511	0.00328	CcSEcCtD
Imipramine—Constipation—Lamivudine—hepatitis B	0.000507	0.00325	CcSEcCtD
Imipramine—Feeling abnormal—Lamivudine—hepatitis B	0.000488	0.00314	CcSEcCtD
Imipramine—Gastrointestinal pain—Lamivudine—hepatitis B	0.000485	0.00311	CcSEcCtD
Imipramine—Urticaria—Lamivudine—hepatitis B	0.000471	0.00302	CcSEcCtD
Imipramine—Body temperature increased—Lamivudine—hepatitis B	0.000469	0.00301	CcSEcCtD
Imipramine—Abdominal pain—Lamivudine—hepatitis B	0.000469	0.00301	CcSEcCtD
Imipramine—CYP1A2—blood—hepatitis B	0.000458	0.013	CbGeAlD
Imipramine—HTR7—liver—hepatitis B	0.000449	0.0127	CbGeAlD
Imipramine—CYP2B6—blood—hepatitis B	0.000439	0.0124	CbGeAlD
Imipramine—CYP2C19—liver—hepatitis B	0.000439	0.0124	CbGeAlD
Imipramine—ADRA1A—liver—hepatitis B	0.000433	0.0123	CbGeAlD
Imipramine—Asthenia—Lamivudine—hepatitis B	0.000425	0.00273	CcSEcCtD
Imipramine—Pruritus—Lamivudine—hepatitis B	0.000419	0.00269	CcSEcCtD
Imipramine—CYP2E1—blood—hepatitis B	0.000412	0.0117	CbGeAlD
Imipramine—Diarrhoea—Lamivudine—hepatitis B	0.000406	0.0026	CcSEcCtD
Imipramine—Dizziness—Lamivudine—hepatitis B	0.000392	0.00252	CcSEcCtD
Imipramine—Vomiting—Lamivudine—hepatitis B	0.000377	0.00242	CcSEcCtD
Imipramine—Rash—Lamivudine—hepatitis B	0.000374	0.0024	CcSEcCtD
Imipramine—Dermatitis—Lamivudine—hepatitis B	0.000373	0.0024	CcSEcCtD
Imipramine—Headache—Lamivudine—hepatitis B	0.000371	0.00238	CcSEcCtD
Imipramine—CYP1A2—liver—hepatitis B	0.000358	0.0101	CbGeAlD
Imipramine—HTR2A—blood—hepatitis B	0.000358	0.0101	CbGeAlD
Imipramine—Nausea—Lamivudine—hepatitis B	0.000352	0.00226	CcSEcCtD
Imipramine—CYP2B6—liver—hepatitis B	0.000343	0.00971	CbGeAlD
Imipramine—CYP3A4—blood—hepatitis B	0.000332	0.00938	CbGeAlD
Imipramine—CYP2D6—blood—hepatitis B	0.000326	0.00923	CbGeAlD
Imipramine—CYP2E1—liver—hepatitis B	0.000322	0.00912	CbGeAlD
Imipramine—HTR2A—liver—hepatitis B	0.00028	0.00792	CbGeAlD
Imipramine—CYP3A4—liver—hepatitis B	0.000259	0.00734	CbGeAlD
Imipramine—CYP2D6—liver—hepatitis B	0.000255	0.00722	CbGeAlD
Imipramine—Desipramine—CYP2A6—hepatitis B	0.000251	0.187	CrCbGaD
Imipramine—ABCB1—blood—hepatitis B	0.000235	0.00664	CbGeAlD
Imipramine—Oxcarbazepine—ALB—hepatitis B	0.000212	0.158	CrCbGaD
Imipramine—ABCB1—liver—hepatitis B	0.000184	0.00519	CbGeAlD
Imipramine—Acepromazine—ALB—hepatitis B	0.00016	0.119	CrCbGaD
Imipramine—Thioproperazine—ALB—hepatitis B	0.000157	0.117	CrCbGaD
Imipramine—Pipotiazine—ALB—hepatitis B	0.000154	0.115	CrCbGaD
Imipramine—Clomipramine—ALB—hepatitis B	0.000122	0.0908	CrCbGaD
Imipramine—Nortriptyline—ALB—hepatitis B	0.000119	0.0887	CrCbGaD
Imipramine—Chlorpromazine—ALB—hepatitis B	8.36e-05	0.0623	CrCbGaD
Imipramine—Amitriptyline—ALB—hepatitis B	8.27e-05	0.0616	CrCbGaD
Imipramine—ADRA1D—GPCR downstream signaling—IL2—hepatitis B	1.35e-05	0.000196	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—F2—hepatitis B	1.35e-05	0.000196	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—F2—hepatitis B	1.35e-05	0.000195	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CXCL10—hepatitis B	1.35e-05	0.000195	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CCR5—hepatitis B	1.34e-05	0.000194	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL2—hepatitis B	1.31e-05	0.000189	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.3e-05	0.000188	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GOT1—hepatitis B	1.29e-05	0.000187	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GGT1—hepatitis B	1.29e-05	0.000187	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—F2—hepatitis B	1.27e-05	0.000184	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—F2—hepatitis B	1.27e-05	0.000184	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GOT1—hepatitis B	1.27e-05	0.000183	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GGT1—hepatitis B	1.27e-05	0.000183	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CCR5—hepatitis B	1.26e-05	0.000182	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CYP2A6—hepatitis B	1.25e-05	0.000181	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GGT2—hepatitis B	1.24e-05	0.00018	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCL10—hepatitis B	1.24e-05	0.00018	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL2—hepatitis B	1.23e-05	0.000178	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CYP2A6—hepatitis B	1.22e-05	0.000177	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCL10—hepatitis B	1.22e-05	0.000177	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCL10—hepatitis B	1.22e-05	0.000176	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCL10—hepatitis B	1.21e-05	0.000176	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCL10—hepatitis B	1.21e-05	0.000175	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCL10—hepatitis B	1.2e-05	0.000174	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—F2—hepatitis B	1.2e-05	0.000174	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCL10—hepatitis B	1.2e-05	0.000173	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—IL2—hepatitis B	1.18e-05	0.000171	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—IL2—hepatitis B	1.17e-05	0.00017	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.17e-05	0.000169	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CYP2A6—hepatitis B	1.15e-05	0.000167	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—F2—hepatitis B	1.15e-05	0.000166	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GOT2—hepatitis B	1.13e-05	0.000164	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—PTEN—hepatitis B	1.13e-05	0.000164	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—IL2—hepatitis B	1.12e-05	0.000163	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GOT2—hepatitis B	1.11e-05	0.00016	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CCR5—hepatitis B	1.1e-05	0.000159	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CCR5—hepatitis B	1.09e-05	0.000158	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.08e-05	0.000157	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—F2—hepatitis B	1.08e-05	0.000156	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL2—hepatitis B	1.07e-05	0.000155	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—PTEN—hepatitis B	1.07e-05	0.000155	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL2—hepatitis B	1.07e-05	0.000154	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCR5—hepatitis B	1.04e-05	0.000151	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GOT2—hepatitis B	1.04e-05	0.000151	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—IL2—hepatitis B	1.04e-05	0.00015	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL2—hepatitis B	1.02e-05	0.000148	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—IL2—hepatitis B	1.02e-05	0.000148	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—IL2—hepatitis B	1.02e-05	0.000147	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—IL2—hepatitis B	1.01e-05	0.000147	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—IL2—hepatitis B	1.01e-05	0.000146	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—IL2—hepatitis B	1e-05	0.000145	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—IL2—hepatitis B	9.98e-06	0.000145	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GGT1—hepatitis B	9.78e-06	0.000142	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GOT1—hepatitis B	9.78e-06	0.000142	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CYP2A6—hepatitis B	9.76e-06	0.000141	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCR5—hepatitis B	9.62e-06	0.000139	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GGT1—hepatitis B	9.54e-06	0.000138	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GOT1—hepatitis B	9.54e-06	0.000138	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCR5—hepatitis B	9.47e-06	0.000137	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCR5—hepatitis B	9.45e-06	0.000137	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCR5—hepatitis B	9.42e-06	0.000136	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL2—hepatitis B	9.41e-06	0.000136	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—F2—hepatitis B	9.4e-06	0.000136	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCR5—hepatitis B	9.39e-06	0.000136	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—F2—hepatitis B	9.35e-06	0.000135	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—ALB—hepatitis B	9.3e-06	0.000135	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCR5—hepatitis B	9.3e-06	0.000135	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—ALB—hepatitis B	9.29e-06	0.000135	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCR5—hepatitis B	9.27e-06	0.000134	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL2—hepatitis B	9.26e-06	0.000134	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL2—hepatitis B	9.24e-06	0.000134	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL2—hepatitis B	9.21e-06	0.000133	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL2—hepatitis B	9.18e-06	0.000133	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	9.1e-06	0.000132	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL2—hepatitis B	9.09e-06	0.000132	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL2—hepatitis B	9.07e-06	0.000131	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GGT1—hepatitis B	8.99e-06	0.00013	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GOT1—hepatitis B	8.99e-06	0.00013	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—F2—hepatitis B	8.95e-06	0.00013	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	8.91e-06	0.000129	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GOT2—hepatitis B	8.82e-06	0.000128	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—ALB—hepatitis B	8.66e-06	0.000125	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL2—hepatitis B	8.55e-06	0.000124	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL2—hepatitis B	8.54e-06	0.000124	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—IL6—hepatitis B	8.51e-06	0.000123	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—IL6—hepatitis B	8.5e-06	0.000123	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CTNNB1—hepatitis B	8.26e-06	0.00012	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—F2—hepatitis B	8.25e-06	0.00012	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CTNNB1—hepatitis B	8.25e-06	0.000119	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—F2—hepatitis B	8.12e-06	0.000118	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—F2—hepatitis B	8.1e-06	0.000117	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—F2—hepatitis B	8.08e-06	0.000117	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL2—hepatitis B	8.07e-06	0.000117	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CDKN1A—hepatitis B	8.07e-06	0.000117	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CDKN1A—hepatitis B	8.06e-06	0.000117	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—F2—hepatitis B	8.05e-06	0.000117	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—PTEN—hepatitis B	8.05e-06	0.000117	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—PTEN—hepatitis B	8.04e-06	0.000116	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL6—hepatitis B	8.03e-06	0.000116	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—NFKB1—hepatitis B	8.01e-06	0.000116	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—NFKB1—hepatitis B	8e-06	0.000116	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—ALB—hepatitis B	8e-06	0.000116	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—F2—hepatitis B	7.97e-06	0.000115	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—F2—hepatitis B	7.95e-06	0.000115	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CTNNB1—hepatitis B	7.79e-06	0.000113	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL2—hepatitis B	7.73e-06	0.000112	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL6—hepatitis B	7.69e-06	0.000111	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GOT1—hepatitis B	7.62e-06	0.00011	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GGT1—hepatitis B	7.62e-06	0.00011	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CDKN1A—hepatitis B	7.61e-06	0.00011	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—PTEN—hepatitis B	7.59e-06	0.00011	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—NFKB1—hepatitis B	7.56e-06	0.000109	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP2A6—hepatitis B	7.53e-06	0.000109	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CTNNB1—hepatitis B	7.46e-06	0.000108	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CDKN1A—hepatitis B	7.29e-06	0.000106	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—PTEN—hepatitis B	7.27e-06	0.000105	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL2—hepatitis B	7.26e-06	0.000105	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NFKB1—hepatitis B	7.24e-06	0.000105	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL6—hepatitis B	7.23e-06	0.000105	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PTEN—hepatitis B	7.1e-06	0.000103	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PTEN—hepatitis B	7.09e-06	0.000103	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CTNNB1—hepatitis B	7.01e-06	0.000102	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.94e-06	0.000101	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ALB—hepatitis B	6.88e-06	9.96e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CDKN1A—hepatitis B	6.85e-06	9.92e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PTEN—hepatitis B	6.84e-06	9.9e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GOT2—hepatitis B	6.81e-06	9.86e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NFKB1—hepatitis B	6.8e-06	9.85e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ALB—hepatitis B	6.74e-06	9.76e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TGFB1—hepatitis B	6.67e-06	9.66e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TGFB1—hepatitis B	6.66e-06	9.65e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PTEN—hepatitis B	6.61e-06	9.57e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL2—hepatitis B	6.33e-06	9.17e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—hepatitis B	6.3e-06	9.12e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL2—hepatitis B	6.3e-06	9.12e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TGFB1—hepatitis B	6.29e-06	9.11e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—hepatitis B	6.27e-06	9.08e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CTNNB1—hepatitis B	6.11e-06	8.85e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PTEN—hepatitis B	6.1e-06	8.84e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CTNNB1—hepatitis B	6.08e-06	8.81e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL2—hepatitis B	6.03e-06	8.73e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TGFB1—hepatitis B	6.03e-06	8.73e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—hepatitis B	6e-06	8.69e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CDKN1A—hepatitis B	5.97e-06	8.65e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PTEN—hepatitis B	5.96e-06	8.63e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CDKN1A—hepatitis B	5.94e-06	8.6e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NFKB1—hepatitis B	5.93e-06	8.59e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PTEN—hepatitis B	5.93e-06	8.58e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NFKB1—hepatitis B	5.9e-06	8.54e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GOT1—hepatitis B	5.88e-06	8.51e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GGT1—hepatitis B	5.88e-06	8.51e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CTNNB1—hepatitis B	5.82e-06	8.43e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CDKN1A—hepatitis B	5.69e-06	8.23e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PTEN—hepatitis B	5.67e-06	8.22e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TGFB1—hepatitis B	5.67e-06	8.21e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NFKB1—hepatitis B	5.65e-06	8.18e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL2—hepatitis B	5.56e-06	8.05e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—hepatitis B	5.53e-06	8.01e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—hepatitis B	5.49e-06	7.95e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—hepatitis B	5.49e-06	7.95e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL2—hepatitis B	5.47e-06	7.92e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL2—hepatitis B	5.46e-06	7.9e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—hepatitis B	5.44e-06	7.88e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL2—hepatitis B	5.44e-06	7.88e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—hepatitis B	5.43e-06	7.86e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL2—hepatitis B	5.42e-06	7.85e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—hepatitis B	5.41e-06	7.84e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—hepatitis B	5.4e-06	7.81e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL2—hepatitis B	5.37e-06	7.78e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CTNNB1—hepatitis B	5.37e-06	7.77e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL2—hepatitis B	5.36e-06	7.76e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—hepatitis B	5.34e-06	7.74e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—hepatitis B	5.33e-06	7.72e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CTNNB1—hepatitis B	5.28e-06	7.65e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CTNNB1—hepatitis B	5.27e-06	7.63e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CTNNB1—hepatitis B	5.25e-06	7.61e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTEN—hepatitis B	5.25e-06	7.6e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN1A—hepatitis B	5.24e-06	7.59e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CTNNB1—hepatitis B	5.24e-06	7.58e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PTEN—hepatitis B	5.23e-06	7.57e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NFKB1—hepatitis B	5.21e-06	7.54e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ALB—hepatitis B	5.2e-06	7.53e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CTNNB1—hepatitis B	5.18e-06	7.51e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—hepatitis B	5.18e-06	7.5e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CTNNB1—hepatitis B	5.17e-06	7.49e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN1A—hepatitis B	5.16e-06	7.47e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN1A—hepatitis B	5.15e-06	7.45e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PTEN—hepatitis B	5.15e-06	7.45e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTEN—hepatitis B	5.14e-06	7.45e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PTEN—hepatitis B	5.14e-06	7.44e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN1A—hepatitis B	5.13e-06	7.43e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NFKB1—hepatitis B	5.12e-06	7.42e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PTEN—hepatitis B	5.12e-06	7.41e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN1A—hepatitis B	5.11e-06	7.41e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NFKB1—hepatitis B	5.11e-06	7.4e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PTEN—hepatitis B	5.1e-06	7.39e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NFKB1—hepatitis B	5.09e-06	7.38e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NFKB1—hepatitis B	5.08e-06	7.35e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ALB—hepatitis B	5.08e-06	7.35e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN1A—hepatitis B	5.06e-06	7.33e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PTEN—hepatitis B	5.05e-06	7.32e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN1A—hepatitis B	5.05e-06	7.31e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PTEN—hepatitis B	5.04e-06	7.3e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NFKB1—hepatitis B	5.03e-06	7.28e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—hepatitis B	5.03e-06	7.28e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—hepatitis B	5.02e-06	7.27e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NFKB1—hepatitis B	5.02e-06	7.26e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—hepatitis B	4.96e-06	7.19e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TGFB1—hepatitis B	4.94e-06	7.15e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TGFB1—hepatitis B	4.91e-06	7.12e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ALB—hepatitis B	4.78e-06	6.93e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—hepatitis B	4.74e-06	6.87e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TGFB1—hepatitis B	4.7e-06	6.81e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—hepatitis B	4.67e-06	6.76e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—hepatitis B	4.54e-06	6.58e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TGFB1—hepatitis B	4.34e-06	6.28e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—hepatitis B	4.27e-06	6.18e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TGFB1—hepatitis B	4.27e-06	6.18e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TGFB1—hepatitis B	4.26e-06	6.17e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TGFB1—hepatitis B	4.24e-06	6.15e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TGFB1—hepatitis B	4.23e-06	6.13e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TGFB1—hepatitis B	4.19e-06	6.07e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TGFB1—hepatitis B	4.18e-06	6.05e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—hepatitis B	4.07e-06	5.89e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ALB—hepatitis B	4.05e-06	5.87e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—hepatitis B	4.04e-06	5.86e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTEN—hepatitis B	3.97e-06	5.75e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTEN—hepatitis B	3.87e-06	5.61e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—hepatitis B	3.87e-06	5.61e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—hepatitis B	3.72e-06	5.39e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—hepatitis B	3.7e-06	5.36e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTEN—hepatitis B	3.65e-06	5.28e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—hepatitis B	3.57e-06	5.17e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—hepatitis B	3.54e-06	5.13e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—hepatitis B	3.51e-06	5.09e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—hepatitis B	3.5e-06	5.08e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—hepatitis B	3.49e-06	5.06e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—hepatitis B	3.48e-06	5.04e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—hepatitis B	3.45e-06	4.99e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—hepatitis B	3.44e-06	4.98e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—hepatitis B	3.27e-06	4.73e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—hepatitis B	3.22e-06	4.66e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—hepatitis B	3.21e-06	4.65e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—hepatitis B	3.2e-06	4.63e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—hepatitis B	3.19e-06	4.62e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—hepatitis B	3.16e-06	4.57e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—hepatitis B	3.15e-06	4.56e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ALB—hepatitis B	3.13e-06	4.53e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTEN—hepatitis B	3.09e-06	4.48e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTEN—hepatitis B	2.39e-06	3.45e-05	CbGpPWpGaD
